Biotts
Last verified 2026-05-13. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2026-04-23attributed |
| Founded | 2018 |
| Headquarters | Wroclaw |
| Industry | pharma |
| Stage | unknown |
| Website | biotts.com |
Biotts develops Multifunctional Transdermal Carrier technology that delivers small and large drug molecules through the skin without injections. It serves pharma and biotech partners reformulating injectables into patches and topicals to improve patient adherence. The MTC platform can move proteins as large as 150 kDa across skin, a size range conventional transdermal patches simply cannot deliver.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-23 | grant | $2.7M | undisclosed |
Detected tech stack
WordPress, Apache HTTP Server, Yoast SEO 27.6, Google Analytics, Google Tag Manager, Site Kit 1.179.0, DoubleClick Floodlight, Contact Form 7 6.1.6, PHP, MySQL, apache
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | biotts.com, read 2026-05-13 |
| Description | self-reported | biotts.com, read 2026-05-13 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.